No Detail Found!

Effect of Metformin Alone Compared with Metformin Plus Simvastatin on Polycystic Ovarian Syndrome in Pakistani Women.

Author(s)
Misbah Malik Department of Obstetrics and Gynaecology, Maternal and Child Health Centre, Unit II, Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan
Nasira Tasnim Department of Obstetrics and Gynaecology, Maternal and Child Health Centre, Unit II, Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan
Ghazala Mahmud Department of Obstetrics and Gynaecology, Maternal and Child Health Centre, Unit II, Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan
Abstract
Objective: To determine the efficacy of metformin alone versus metformin plus simvastatin for treatment of polycystic ovarian syndrome (PCOS). Study Design: Randomized controlled trial. Place and Duration of Study: Maternal and Child Health Centre, Unit II, Pakistan Institute of Medical Sciences (PIMS), from November 2014 to April 2015. Methodology: One hundred and eight patients (108) were randomly divided into metformin group (n=54) and metformin plus simvastatin group (n=54), detailed clinical history, including menstrual details, was taken with thorough examination performed. Baseline ultrasound was performed to evaluate ovarian size and these were considered enlarged with volume >10cc or with >12 follicles in any one ovary. Blood samples were taken at baseline and after three months of therapy to determine the LH/FSH ratio and lipid profile. Efficacy was defined as >15% decrease in the baseline values. Results: The mean age of patients was 28.82 ±7.18 years. Mean BMI of the patients was 22.41 ±1.55 Kg/m2. Efficacy was achieved in 66.7% patients with metformin alone, while in 92.6% with combination medication (p=0.001). Conclusion: The combination of metformin plus simvastatin is more efficacious as compared to metformin alone for management of females with PCOS.
Publication Details
Page(s) 184-187
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 3, Year: 2018

Request the full text from PASTIC

References
KazerooniT,Shojaei-BaghiniA,DehbashiS,AsadiN,GhaffarpasandF,KazerooniY., 2010.Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study,Fertil Steril 94 2208 -13
LindholmÅ,AnderssonL,EliassonM,BixoM, 2008.SundströmPoromaa I. Prevalence of symptoms associated with polycystic ovary syndrome,International J Gynecol Obstet 102 39 -43
WildRA,CarminaE,Diamanti-KandarakisE,DokrasA,Escobar-MorrealeHF,FutterweitW, ., -
RepaciA,GambineriA,PasqualiR, 2011.The role of low-grade inflammation in the polycystic ovary syndrome,Mol Cell Endocrinol 335 30 -41
BanaszewskaB,PawelczykL,SpaczynskiRZ,DulebaAJ, 2011.Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment,J Clin Endocrinol Metab 96 3493 -501
BanaszewskaB,PawelczykL,SpaczynskiRZ,DulebaAJ, 2009.Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial,J Clin Endocrinol Metab 94 4938 -45
SharmaD,DahiyaK,DoraA,GhalautVS, 2006.Effect of rosiglitazone in spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome,J Gynecol Surg 22 151 -6
UmlandE,WeinsteinL,BuchananE,TalbertRL,YeeGC, 2011.A pathophysiologic approach, McGraw -
AubuchonM,LegroRS, 2011.Polycystic ovary syndrome: Current infertility management,Clin Obstet Gynecol 54 675 -84
CareIoLARCo,AnimalsUoL, 1985.Guide for the care, -
2015.,2014 [cited -
CheangKI,HuszarJM,BestAM,SharmaS,EssahPA,NestlerJE, 2009.Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome,Diab Vasc Dis Res 6 110 -9
CarrickE., 2012.The use of simvastatin plus metformin therapy in patients with polycystic ovarian syndrome, -
GambineriA,PelusiC,ManicardiE,VicennatiV,CacciariM,Morselli-LabateAM, 2004.Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome phenotype and associated factors,Diabetes 53 2353 -8
RizzoM,BerneisK,CarminaE,RiniGB, 2008.How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?,Am J Obstet Gynecol 198 e1 -5
0

Citations

0

Downloads

66

Views